At this time, appropriate consultation services should be contacted. The oncology pharmacist should review the complete list of medications the patient is taking, as drug interactions and may affect the pharmacokinetics of the chemotherapy drug. No known antidotes or reversal agents exist for many chemotherapy agents (Goldfrank, 2006; Goodin et al., 2011). As part of this policy, the authors compiled a table of therapeutic agents reported in the medical literature as possible interventions in the event of a chemotherapy overdose (see Table 2) The amount of supporting clinical data for overdose of the agents varied because of limited evidence and reliance o case reports.Attending oncologists should review the primary literature and make assessments based on the strength If indicated, they should obtain and administer an intervention agent to minimize toxicity.